SIRT5 Knockout HEK293 Cell Line
Cat.No.:
EDC07605
Species:
Human
Cell Name:
HEK293
Gene:
SIRT5
Gene ID:
23408
Size:
1×10⁶cells
SIRT5 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07605 |
|---|---|
| Product Name | SIRT5 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SIRT5 |
| NCBI Gene ID | |
| Gene Synonyms | SIR2L5 |
| Summary |
This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class III of the sirtuin family. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2010]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SIRT5 function, SIRT5 Knockout HEK293 Cell Line or SIRT5 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SIRT5's role as a unique mitochondrial desuccinylase/demalonylase/deglutarylase or its emerging functions in metabolic regulation and cancer. The Knockout line is the standard tool for asking whether SIRT5 is required for removing these acidic PTMs from mitochondrial substrates — SIRT5 is the only mammalian sirtuin with substantial desuccinylation/demalonylation activity, distinguishing it functionally from the other six sirtuins. Overexpression is useful for testing SIRT5 in metabolic stress contexts or for assessing its role in cancer biology.
For sirtuin research, the EDITGENE SIRT5 Knockout in HEK293 is the standard mechanistic platform — HEK293 supports the biochemical and proteomic analyses needed for SIRT5 substrate characterization. Rescue with wild-type or catalytically-dead (H158Y) SIRT5 is the standard specificity control. The knockout serves as a critical genetic specificity tool for SIRT5-selective compounds in development.
What are the application scenarios for this model?
Primary applications:
• Mitochondrial PTM profiling: lysine succinylation, malonylation, and glutarylation analysis by mass spectrometry — these PTMs accumulate in SIRT5-null mitochondria.
• Metabolic enzyme regulation: SIRT5 substrates (CPS1, SOD1, GAPDH, PKM2, others) activity and acidic acyl-modification status analysis.
• In vitro desuccinylation: SIRT5 enzymatic activity assays using succinyl-peptide substrates with NAD⁺ supplementation.
• Cancer biology: proliferation, metabolic stress sensitivity assays given SIRT5's reported roles in tumor cell metabolism.
EDITGENE recommends this model for researchers investigating SIRT5 biology, mitochondrial acidic PTM regulation, and metabolic enzyme post-translational modifications.
Is this SIRT5 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. SIRT5 rescue experiments require attention to mitochondrial targeting and catalytic activity:
• Construct design: use a codon-modified SIRT5 sequence with a small C-terminal tag (FLAG, HA). SIRT5 contains an N-terminal mitochondrial targeting sequence — N-terminal tags must not disrupt mitochondrial import.
• Catalytically-dead rescue: the H158Y mutation abolishes desuccinylase/demalonylase activity and is the standard specificity control.
• Mitochondrial localization validation: confirm mitochondrial localization by TOM20 co-staining or mitochondrial fractionation before functional assays.
• Functional readout: rescue should restore desuccinylation of SIRT5 substrates measured by anti-succinyl-lysine Western blot.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download